Clinical Trial

TRAP Study: Testosterone for Androgen Receptor Polymorphism

Study acronym: TRAP
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To determine whether pretreatment with transdermal testosterone increases the number of cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in patients with low ovarian reserve and androgen receptor polymorphism undergoing intracytoplasmic sperm injection (ICSI).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-22.
Trial Details
NCT Number NCT06195163
Lead Sponsor Instituto Bernabeu
Conditions Fertility Disorders
Enrollment 100 participants
Start Date 2025-09-30
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-09